The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate Carcinoma
Author:
Affiliation:
1. Departments of Urology and Clinical Chemistry, Academic Hospital Rotterdam, Rotterdam, The Netherlands.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference14 articles.
1. Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications;Shinohara;J. Urol.,1994
2. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer;Bluestein;J. Urol.,1994
3. Use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer;Partin;J. Urol.,1993
4. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer;Stenman;Cancer Res.,1991
5. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin;Lilja;Clin. Chem.,1991
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple Primary Tumors Originating From the Prostate and Colorectum A Clinical-Pathological and Therapeutic Challenge;American Journal of Men's Health;2021-09
2. Enrollment Criteria Controversies for Active Surveillance and Triggers for Conversion to Treatment in Prostate Cancer;Journal of the National Comprehensive Cancer Network;2012-09
3. The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml;International Urology and Nephrology;2012-02-08
4. Validity and Legacy of Prostate-Specific Antigen (PSA) and PSA-Based Parameters and Isoforms in the New Millennium;European Urology;2010-06
5. The Outcome of Prostate Cancer Screening in a Normal Japanese Population with PSA of 2-4 ng/ml and the Free/Total PSA Under 12%;Japanese Journal of Clinical Oncology;2008-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3